Hospira irinotecan hydrochloride trihydrate IV Infusion 100 mg

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

متاح من:

Hospira Australia Pty Ltd

INN (الاسم الدولي):

irinotecan hydrochloride trihydrate

الشكل الصيدلاني:

Injection, intravenous infusion

تركيب:

Excipient Ingredients: lactic acid; sorbitol; water for injections

طريقة التعاطي:

Intravenous Infusion

الوحدات في الحزمة:

1 x 5 mL vial

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

(S1) This Schedule is intentionally blank

الخصائص العلاجية:

Small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, ovarian cancer, stomach cancer (inoperable or recurrent), colorectal cancer (inoperable or recurrent), breast cancer (inoperable or recurrent), squamous cell carcinoma, malignant lymphoma (non Hodgkin's disease).

ملخص المنتج:

Visual Identification: A clear, colourless to pale yellow solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Room temperature; Container Closure: Neither child resistant closure nor restricted flow insert

الوضع إذن:

Licence status A

تاريخ الترخيص:

2013-01-31